AI Innovation through passion and collaboration

Our story began in 2020 with the establishment of "Expert BioSystems AI" as a pioneering research and development initiative within "Expert BioSystems." From the outset, we committed ourselves to exploring the vast potential of Artificial Intelligence and Large Language Models (LLMs), embarking on an ambitious journey to create an intelligent agent capable of performing vital functions typically reserved for primary physicians in the healthcare sector. By 2025, as we recognized the unique contributions and burgeoning needs of our innovation efforts, "Expert BioSystems AI" evolved into an independent entity, dedicated to a singular mission: the development of "Agentic AI." This innovative platform is designed not only to serve as a primary care provider but also to facilitate the cultivation of Specialized Language Models attuned to specific medical fields, including breast cancer, prostate cancer, cardiology and ... By harnessing advanced AI technologies, we aim to significantly enhance healthcare delivery and accessibility, thereby transforming patient care across diverse medical domains.

 

Ali Eghlima, Ph.D
Founder & CTO

At the core of our strategic vision is our Founder and CTO, Ali Eghlima, a distinguished Data Scientist whose exceptional knowledge and skills serve as a vital bridge between the fields of advanced artificial intelligence and healthcare innovation. Ali's extensive expertise encompasses a wide array of sophisticated technologies, including large language models (LLMs), small language models (SLMs), and nano language models, all of which he adeptly integrates into the healthcare and life sciences sectors. This integration fuels a holistic approach to resolving some of the most formidable challenges within the industry. His technical acumen spans pivotal areas such as AI methodologies, high-performance computing, numerical analysis, big data analytics, real-time distributed computing, and cybersecurity, positioning him uniquely to navigate the complex data landscape that underpins modern healthcare systems. Currently, Ali is spearheading several transformative initiatives that focus on architecting and deploying an innovative Diagnosis Agent, which is envisioned to function as a primary physician, enhancing diagnostic accuracy and patient care. Furthermore, in response to the inherent challenges associated with the accuracy of single LLM results. Ali and his team are actively researching novel architectural frameworks aimed at effectively combining the outputs of multiple LLMs. This approach not only seeks to enhance the reliability of AI-generated insights but also embodies Ali’s proactive problem-solving mindset and relentless commitment to achieving substantial advancements in healthcare delivery, exemplifying his leadership in the ongoing transformation driven by cutting-edge technology.

We invite you to explore our Research page for deeper insights into our investigations into SLMs and Nano Language Models. Our team is actively seeking innovative applications of these models to revolutionize data analysis, streamline communication, and enhance decision-making processes in complex medical environments, ultimately aiming to contribute essential findings that advance the understanding of language processing in healthcare settings. For a comprehensive overview of our ongoing projects and future initiatives, we encourage you to delve into our Research page. We invite you to visit our Research page to gain deeper insights into our current focus is on Small Language Models (SLMs) and Nano Language Models within the domains of Healthcare and Life Sciences. Our dedicated team is exploring innovative applications of these models to enhance data analysis, streamline communication, and improve decision-making processes in complex medical environments. By leveraging cutting-edge technology, we aim to contribute valuable findings that will advance the understanding of language processing in healthcare settings. For a comprehensive overview of our ongoing projects and future initiatives, please explore our Research page.

 

·